Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HA54
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006396 | RNA processing | 6 | 11 |
GO:0006399 | tRNA metabolic process | 7 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008033 | tRNA processing | 8 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016070 | RNA metabolic process | 5 | 11 |
GO:0034470 | ncRNA processing | 7 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0034660 | ncRNA metabolic process | 6 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
GO:0001522 | pseudouridine synthesis | 6 | 6 |
GO:0006400 | tRNA modification | 6 | 1 |
GO:0009451 | RNA modification | 5 | 6 |
GO:0031119 | tRNA pseudouridine synthesis | 7 | 1 |
GO:0043412 | macromolecule modification | 4 | 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004730 | pseudouridylate synthase activity | 5 | 6 |
GO:0005488 | binding | 1 | 11 |
GO:0009982 | pseudouridine synthase activity | 4 | 11 |
GO:0016829 | lyase activity | 2 | 6 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 6 |
GO:0016836 | hydro-lyase activity | 4 | 6 |
GO:0016853 | isomerase activity | 2 | 11 |
GO:0016866 | intramolecular transferase activity | 3 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0106029 | tRNA pseudouridine synthase activity | 5 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 103 | 107 | PF00656 | 0.479 |
CLV_NRD_NRD_1 | 213 | 215 | PF00675 | 0.327 |
CLV_NRD_NRD_1 | 243 | 245 | PF00675 | 0.533 |
CLV_NRD_NRD_1 | 268 | 270 | PF00675 | 0.320 |
CLV_NRD_NRD_1 | 327 | 329 | PF00675 | 0.384 |
CLV_NRD_NRD_1 | 475 | 477 | PF00675 | 0.318 |
CLV_PCSK_KEX2_1 | 157 | 159 | PF00082 | 0.488 |
CLV_PCSK_KEX2_1 | 213 | 215 | PF00082 | 0.327 |
CLV_PCSK_KEX2_1 | 243 | 245 | PF00082 | 0.382 |
CLV_PCSK_KEX2_1 | 268 | 270 | PF00082 | 0.320 |
CLV_PCSK_KEX2_1 | 327 | 329 | PF00082 | 0.384 |
CLV_PCSK_KEX2_1 | 480 | 482 | PF00082 | 0.296 |
CLV_PCSK_PC1ET2_1 | 157 | 159 | PF00082 | 0.602 |
CLV_PCSK_PC1ET2_1 | 480 | 482 | PF00082 | 0.287 |
CLV_PCSK_PC7_1 | 153 | 159 | PF00082 | 0.465 |
CLV_PCSK_PC7_1 | 476 | 482 | PF00082 | 0.287 |
CLV_PCSK_SKI1_1 | 182 | 186 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.455 |
CLV_PCSK_SKI1_1 | 230 | 234 | PF00082 | 0.229 |
CLV_PCSK_SKI1_1 | 394 | 398 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 477 | 481 | PF00082 | 0.379 |
CLV_Separin_Metazoa | 422 | 426 | PF03568 | 0.347 |
DEG_APCC_DBOX_1 | 243 | 251 | PF00400 | 0.405 |
DEG_APCC_DBOX_1 | 408 | 416 | PF00400 | 0.505 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.588 |
DEG_SPOP_SBC_1 | 330 | 334 | PF00917 | 0.526 |
DOC_CDC14_PxL_1 | 90 | 98 | PF14671 | 0.561 |
DOC_CKS1_1 | 68 | 73 | PF01111 | 0.506 |
DOC_CYCLIN_yCln2_LP_2 | 68 | 74 | PF00134 | 0.503 |
DOC_MAPK_gen_1 | 213 | 221 | PF00069 | 0.343 |
DOC_MAPK_gen_1 | 243 | 249 | PF00069 | 0.369 |
DOC_MAPK_MEF2A_6 | 425 | 434 | PF00069 | 0.269 |
DOC_PP1_RVXF_1 | 5 | 12 | PF00149 | 0.533 |
DOC_PP2B_LxvP_1 | 193 | 196 | PF13499 | 0.405 |
DOC_PP2B_LxvP_1 | 296 | 299 | PF13499 | 0.430 |
DOC_USP7_MATH_1 | 262 | 266 | PF00917 | 0.358 |
DOC_USP7_MATH_1 | 329 | 333 | PF00917 | 0.511 |
DOC_USP7_MATH_1 | 341 | 345 | PF00917 | 0.500 |
DOC_USP7_MATH_1 | 353 | 357 | PF00917 | 0.505 |
DOC_USP7_MATH_1 | 467 | 471 | PF00917 | 0.269 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.544 |
DOC_WW_Pin1_4 | 34 | 39 | PF00397 | 0.710 |
DOC_WW_Pin1_4 | 67 | 72 | PF00397 | 0.563 |
LIG_14-3-3_CanoR_1 | 213 | 222 | PF00244 | 0.475 |
LIG_14-3-3_CanoR_1 | 235 | 239 | PF00244 | 0.380 |
LIG_14-3-3_CanoR_1 | 394 | 399 | PF00244 | 0.529 |
LIG_Actin_WH2_2 | 437 | 454 | PF00022 | 0.287 |
LIG_APCC_ABBA_1 | 507 | 512 | PF00400 | 0.503 |
LIG_BIR_III_2 | 159 | 163 | PF00653 | 0.607 |
LIG_BIR_III_2 | 512 | 516 | PF00653 | 0.529 |
LIG_BRCT_BRCA1_1 | 176 | 180 | PF00533 | 0.470 |
LIG_EH1_1 | 441 | 449 | PF00400 | 0.287 |
LIG_EVH1_1 | 484 | 488 | PF00568 | 0.195 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.609 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.674 |
LIG_FHA_1 | 214 | 220 | PF00498 | 0.455 |
LIG_FHA_1 | 235 | 241 | PF00498 | 0.393 |
LIG_FHA_1 | 68 | 74 | PF00498 | 0.596 |
LIG_FHA_2 | 19 | 25 | PF00498 | 0.527 |
LIG_FHA_2 | 385 | 391 | PF00498 | 0.404 |
LIG_FHA_2 | 491 | 497 | PF00498 | 0.269 |
LIG_FHA_2 | 74 | 80 | PF00498 | 0.585 |
LIG_LIR_Gen_1 | 177 | 188 | PF02991 | 0.400 |
LIG_LIR_Gen_1 | 293 | 301 | PF02991 | 0.481 |
LIG_LIR_Gen_1 | 37 | 44 | PF02991 | 0.484 |
LIG_LIR_Nem_3 | 145 | 151 | PF02991 | 0.533 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 293 | 298 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 311 | 317 | PF02991 | 0.239 |
LIG_LIR_Nem_3 | 37 | 42 | PF02991 | 0.764 |
LIG_LIR_Nem_3 | 387 | 391 | PF02991 | 0.388 |
LIG_LIR_Nem_3 | 505 | 510 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 87 | 93 | PF02991 | 0.513 |
LIG_LYPXL_yS_3 | 93 | 96 | PF13949 | 0.579 |
LIG_MAD2 | 274 | 282 | PF02301 | 0.323 |
LIG_MAD2 | 394 | 402 | PF02301 | 0.353 |
LIG_Pex14_1 | 495 | 499 | PF04695 | 0.317 |
LIG_SH2_CRK | 148 | 152 | PF00017 | 0.613 |
LIG_SH2_CRK | 273 | 277 | PF00017 | 0.343 |
LIG_SH2_CRK | 39 | 43 | PF00017 | 0.487 |
LIG_SH2_NCK_1 | 516 | 520 | PF00017 | 0.481 |
LIG_SH2_SRC | 119 | 122 | PF00017 | 0.453 |
LIG_SH2_SRC | 295 | 298 | PF00017 | 0.470 |
LIG_SH2_SRC | 510 | 513 | PF00017 | 0.457 |
LIG_SH2_SRC | 516 | 519 | PF00017 | 0.479 |
LIG_SH2_STAT3 | 499 | 502 | PF00017 | 0.353 |
LIG_SH2_STAT5 | 119 | 122 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 25 | 28 | PF00017 | 0.667 |
LIG_SH2_STAT5 | 271 | 274 | PF00017 | 0.341 |
LIG_SH2_STAT5 | 295 | 298 | PF00017 | 0.470 |
LIG_SH2_STAT5 | 510 | 513 | PF00017 | 0.407 |
LIG_SH3_3 | 216 | 222 | PF00018 | 0.372 |
LIG_SH3_3 | 32 | 38 | PF00018 | 0.523 |
LIG_SH3_3 | 362 | 368 | PF00018 | 0.638 |
LIG_SH3_3 | 482 | 488 | PF00018 | 0.265 |
LIG_SH3_3 | 494 | 500 | PF00018 | 0.347 |
LIG_SH3_3 | 512 | 518 | PF00018 | 0.407 |
LIG_SUMO_SIM_anti_2 | 419 | 425 | PF11976 | 0.269 |
LIG_SUMO_SIM_par_1 | 245 | 251 | PF11976 | 0.331 |
LIG_SUMO_SIM_par_1 | 517 | 523 | PF11976 | 0.516 |
LIG_TYR_ITIM | 91 | 96 | PF00017 | 0.555 |
LIG_WRC_WIRS_1 | 385 | 390 | PF05994 | 0.395 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.683 |
MOD_CK1_1 | 333 | 339 | PF00069 | 0.626 |
MOD_CK1_1 | 345 | 351 | PF00069 | 0.605 |
MOD_CK1_1 | 37 | 43 | PF00069 | 0.676 |
MOD_CK2_1 | 109 | 115 | PF00069 | 0.615 |
MOD_CK2_1 | 18 | 24 | PF00069 | 0.524 |
MOD_CK2_1 | 220 | 226 | PF00069 | 0.393 |
MOD_CK2_1 | 374 | 380 | PF00069 | 0.425 |
MOD_CK2_1 | 384 | 390 | PF00069 | 0.361 |
MOD_CK2_1 | 467 | 473 | PF00069 | 0.269 |
MOD_GlcNHglycan | 101 | 105 | PF01048 | 0.558 |
MOD_GlcNHglycan | 264 | 267 | PF01048 | 0.349 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.643 |
MOD_GlcNHglycan | 344 | 347 | PF01048 | 0.642 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.677 |
MOD_GlcNHglycan | 469 | 472 | PF01048 | 0.283 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.703 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.574 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.717 |
MOD_GSK3_1 | 329 | 336 | PF00069 | 0.551 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.586 |
MOD_GSK3_1 | 341 | 348 | PF00069 | 0.583 |
MOD_GSK3_1 | 407 | 414 | PF00069 | 0.382 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.631 |
MOD_N-GLC_1 | 164 | 169 | PF02516 | 0.705 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.620 |
MOD_NEK2_1 | 233 | 238 | PF00069 | 0.307 |
MOD_NEK2_1 | 317 | 322 | PF00069 | 0.419 |
MOD_NEK2_1 | 472 | 477 | PF00069 | 0.402 |
MOD_NEK2_2 | 248 | 253 | PF00069 | 0.464 |
MOD_NEK2_2 | 38 | 43 | PF00069 | 0.486 |
MOD_PIKK_1 | 374 | 380 | PF00454 | 0.532 |
MOD_PKA_1 | 213 | 219 | PF00069 | 0.454 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.470 |
MOD_PKA_2 | 234 | 240 | PF00069 | 0.371 |
MOD_PKA_2 | 262 | 268 | PF00069 | 0.329 |
MOD_Plk_1 | 64 | 70 | PF00069 | 0.771 |
MOD_Plk_2-3 | 220 | 226 | PF00069 | 0.508 |
MOD_Plk_4 | 234 | 240 | PF00069 | 0.367 |
MOD_Plk_4 | 435 | 441 | PF00069 | 0.278 |
MOD_Plk_4 | 490 | 496 | PF00069 | 0.269 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.545 |
MOD_ProDKin_1 | 34 | 40 | PF00069 | 0.708 |
MOD_ProDKin_1 | 67 | 73 | PF00069 | 0.563 |
MOD_SUMO_for_1 | 479 | 482 | PF00179 | 0.287 |
MOD_SUMO_rev_2 | 313 | 323 | PF00179 | 0.334 |
TRG_DiLeu_BaEn_1 | 427 | 432 | PF01217 | 0.402 |
TRG_ENDOCYTIC_2 | 148 | 151 | PF00928 | 0.568 |
TRG_ENDOCYTIC_2 | 273 | 276 | PF00928 | 0.343 |
TRG_ENDOCYTIC_2 | 295 | 298 | PF00928 | 0.470 |
TRG_ENDOCYTIC_2 | 314 | 317 | PF00928 | 0.452 |
TRG_ENDOCYTIC_2 | 39 | 42 | PF00928 | 0.484 |
TRG_ENDOCYTIC_2 | 516 | 519 | PF00928 | 0.479 |
TRG_ENDOCYTIC_2 | 93 | 96 | PF00928 | 0.663 |
TRG_ER_diArg_1 | 212 | 214 | PF00400 | 0.326 |
TRG_ER_diArg_1 | 267 | 269 | PF00400 | 0.338 |
TRG_ER_diArg_1 | 326 | 328 | PF00400 | 0.372 |
TRG_NLS_MonoExtC_3 | 475 | 480 | PF00514 | 0.331 |
TRG_NLS_MonoExtN_4 | 476 | 481 | PF00514 | 0.331 |
TRG_Pf-PMV_PEXEL_1 | 230 | 234 | PF00026 | 0.367 |
TRG_Pf-PMV_PEXEL_1 | 374 | 378 | PF00026 | 0.468 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I702 | Leptomonas seymouri | 72% | 79% |
A0A1X0P663 | Trypanosomatidae | 60% | 84% |
A0A3S7WVG1 | Leishmania donovani | 85% | 100% |
A0A422NHE5 | Trypanosoma rangeli | 59% | 86% |
A4HYB9 | Leishmania infantum | 85% | 100% |
D0A0P7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 59% | 89% |
E9AS53 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
Q4QDB3 | Leishmania major | 86% | 100% |
V5BNI6 | Trypanosoma cruzi | 65% | 86% |